Composition and uses of galectin antagonists

Details for Australian Patent Application No. 2004229399 (hide)

International Classifications

Event Publications

20 October 2005 PCT application entered the National Phase

PCT publication WO2004/091634 Priority application(s): WO2004/091634

19 April 2007 Assignment before Grant

Glycogenesys, Inc. The application has been assigned to Marlborough Research and Development Inc.

24 January 2008 Alteration of Name

The name of the applicant has been altered to Prospect Therapeutics, Inc.

5 August 2010 Application Accepted

Published as AU-B-2004229399

2 December 2010 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.